泪道激光联合迪可罗眼膏治疗泪道阻塞的研究  

Analysis of the Treatment of Lacrimal Duct Occlusion with Laser-assisted Dacryocystoplasty and Ofloxacin Salve

作　　者：孙远军[1] 李睿姝[1] 

机构地区：[1]哈尔滨医科大学附属第一医院眼科,黑龙江哈尔滨150001

出　　处：《中国伤残医学》2006年第5期20-21,共2页Chinese Journal of Trauma and Disability Medicine

摘　　要：目的:探讨泪道激光联合迪可罗眼膏治疗泪道阻塞的临床疗效。方法:采用泪道激光泪道成形术联合泪道内分别注入迪可罗眼膏和生理盐水,共治疗泪道阻塞患者106例(120只眼)。随访观察6个月。结果:迪可罗组6个月冲洗通畅率为93.3%,生理盐水组保持通畅率为70.0%,两组疗效差异有显著性(χ2=10.91,P<0.01)。结论:采用泪道激光泪道成形术联合泪道内注入迪可罗眼膏,是成功率较高的治疗泪道阻塞的方法之一。Objective:To evaluate the efficacy of the treatment of lacrimal duct occlusion with laser-assisted dacryocystoplasty and ofloxacin salve. Methods: Laser-assisted dacryocystoplasty using Nd:YAG laser and injection with ofloxacin salve or physiological saline were performed on 120 eyes with lacrimal duct occlusion. Mean follow-up time was 6 months. Results: The success rate of group of ofloxacin salve was 93.9% and significantly higher than that of physiological saline(P<0.01). Conclution: The treatment of lacrimal duct occlusion with laser-assisted dacryocystoplasty and ofloxacin salve is an effective and safe therapy in lacrimal duct occlution.

关 键 词：泪道激光 迪可罗眼膏 泪道阻塞 

分 类 号：R777.2[医药卫生—眼科]